Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus
- Briones-Aranda Alfredo
- Ramírez-Carballo Javier
- Gómez Bernardo Alfredo Romero
- Villa Victor Manuel Vega
- Pérez Manuela Castellanos
- Parra Esmeralda Garcia
- Santeliz-Montero Hugo Roberto
Publication date
March 2018
DOI Publisher
Sciendo ISSN
2284-6417 Journal
2284-6417Abstract
Background and aims: Bromocriptine is a dopaminergic (D2) agonist that has shown hypoglycemic and normotensive activity in preclinical and clinical studies. The main objective of this study was to investigate the effect of bromocriptine plus metformin on glycaemia and blood pressure in patients with type 2 diabetes mellitus (T2DM)
Add to ORKG